86.02
Ishares U S Pharmaceuticals Etf stock is traded at $86.02, with a volume of 77,480.
It is up +0.24% in the last 24 hours and up +14.81% over the past month.
See More
Previous Close:
$85.85
Open:
$85.75
24h Volume:
77,480
Relative Volume:
1.23
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.84%
1M Performance:
+14.81%
6M Performance:
+35.31%
1Y Performance:
+25.09%
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Name
Ishares U S Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare IHE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IHE
Ishares U S Pharmaceuticals Etf
|
86.06 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.67 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
680.24 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
683.60 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
257.47 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
614.63 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Stock (IHE) Latest News
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs - Benzinga
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - Yahoo Finance
Pharmaceutical Sector Surges on Policy Shifts and Innovation - Ad-hoc-news.de
Pharma Stocks in the World Market for TVC:GOLD by GlobalWolfStreet - TradingView
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? - sharewise.com
Pharma ETF (IHE) Hit a 52-Week High - sharewise.com
iShares U.S. Pharmaceutical ETF (NY: IHE - Markets Financial Content
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - NewsBreak: Local News & Alerts
Is iShares U.S. Pharmaceutical ETF stock a top dividend aristocrat candidateEarnings Risk Report & Daily Growth Stock Tips - newser.com
Is iShares U.S. Pharmaceutical ETF stock attractive post correctionJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - sharewise.com
How dovish Fed policy supports iShares U.S. Pharmaceutical ETF stockQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - newser.com
How iShares U.S. Pharmaceutical ETF stock trades under stagflationTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Can iShares U.S. Pharmaceutical ETF stock test all time highs2025 Earnings Impact & High Conviction Trade Alerts - newser.com
Is iShares U.S. Pharmaceutical ETF stock positioned for secular growthMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
Truist Financial Corp Has $593,000 Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
3,967 Shares in iShares U.S. Pharmaceuticals ETF $IHE Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Here's How This Pharmaceutical Giant Is Protecting Itself From President Trump's Tariffs. Should It Matter to Investors? - The Motley Fool
Can iShares U.S. Pharmaceutical ETF stock double in coming yearsQuarterly Portfolio Report & Long-Term Growth Portfolio Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
How iShares U.S. Pharmaceutical ETF stock trades in high volatilityJuly 2025 Earnings & Entry and Exit Point Strategies - newser.com
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Sahm
U.S. Capital Wealth Advisors LLC Has $437,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Trump’s Pharma Tariffs Boost US Drug Stocks as Europe’s and Asia’s Drop - NTD News
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise.com
10 Best Pharma Stocks to Buy According to Billionaires - Insider Monkey
iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.3124 - MSN
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Raymond James Financial Inc. Sells 6,443 Shares of iShares U.S. Pharmaceuticals ETF $IHE - Defense World
How Is Bristol-Myers’ Stock Performance Compared to Other Pharma Stocks? - Yahoo Finance
BlackRock calls out state officials for ‘politicization’ of public pensions - ESG Dive
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - Inkl
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
HighTower Advisors LLC Has $944,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
PNC Financial Services Group Inc. Acquires 216 Shares of iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Should You Invest in the iShares U.S. Financials ETF (IYF)? - Yahoo Finance
LPL Financial LLC Has $2.88 Million Stock Holdings in First Trust Nasdaq Pharmaceuticals ETF $FTXH - Defense World
Ishares U S Pharmaceuticals Etf Stock (IHE) Financials Data
There is no financial data for Ishares U S Pharmaceuticals Etf (IHE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):